Gilbert Marks

Gilbert Marks

Direttore/Membro del Consiglio presso AN2 THERAPEUTICS, INC.

Patrimonio netto: 454 395 $ in data 31/08/2026

68 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Gilbert Lynn Marks currently serves as Office Director at Biomedical Advanced Research & Development Authority and as Independent Director at AN2 Therapeutics, Inc. since 2020.
Former positions include Chairman at Global Alliance for TB Drug Development from 2006 to 2018, Chairman-Cures Acceleration Network Review Board at National Center for Advancing Translational Sciences from 2016 to 2021, Director at Women Organized Against Rape from 2017 to 2021, Member-Scientific Review Board at MMV Medicines for Malaria Venture from 2020 to 2021, Senior Vice President-Research & Development at GlaxoSmithKline LLC from 1993 to 2017, and Vice President at Tunnell Government Services, Inc. from 2017 to 2021.
Education includes undergraduate studies at Auburn University and a doctorate from the University of South Alabama.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
10/07/2026 81.873 ( 0,22% ) 454 395 $ 31/08/2026

Posizioni attive di Gilbert Marks

SocietàPosizioneInizio
AN2 THERAPEUTICS, INC. Direttore/Membro del Consiglio 01/02/2020
Biomedical Advanced Research & Development Authority
Corporate Officer/Principal -

Precedenti posizioni note di Gilbert Marks

SocietàPosizioneFine
Corporate Officer/Principal 01/09/2021
Corporate Officer/Principal 01/09/2021
Corporate Officer/Principal 01/01/2021
Direttore/Membro del Consiglio 01/01/2021
Presidente 01/01/2018
Vedi nel dettaglio l'esperienza di Gilbert Marks

Formazione di Gilbert Marks

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

79

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Services

Health Technology

Biomedical Advanced Research & Development Authority

Government

Commercial Services

Health Technology

  1. Mercati
  2. Insiders
  3. Gilbert Marks
ULTIMI ORARI | -40%: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA